D. E. Shaw & Co., Inc. Illumina, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 161,088 shares of ILMN stock, worth $21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

161,088

Previous 202,566 20.48%

Holding current value

$21 Million

Previous $27.8 Million 39.55%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $4.19 Million - $5.54 Million	-41,478 Reduced 20.48%	161,088 $16.8 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $19.8 Million - $22.9 Million	-155,402 Reduced 43.41%	202,566 $27.8 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $32.1 Million - $49.3 Million	345,618 Added 2798.53%	357,968 $49.8 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $1.59 Million - $2.38 Million	12,350 New	12,350 $1.7 Million
Q1 2023 May 15, 2023	SELL	$193.75 - $232.55 $858,118 - $1.03 Million	-4,429 Reduced 57.0%	3,341 $776,000
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $26.4 Million - $34.3 Million	-141,219 Reduced 94.78%	7,770 $1.57 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $35.4 Million - $45.4 Million	-199,551 Reduced 57.25%	148,989 $28.4 Million
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $50.3 Million - $102 Million	276,966 Added 386.96%	348,540 $64.3 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $9.12 Million - $12.7 Million	-30,021 Reduced 29.55%	71,574 $25 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $107 Million - $130 Million	-307,248 Reduced 75.15%	101,595 $38.7 Million
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $122 Million - $158 Million	301,307 Added 280.19%	408,843 $166 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $16.9 Million - $21.8 Million	-45,199 Reduced 29.59%	107,536 $50.9 Million
Q1 2021 May 17, 2021	BUY	$361.28 - $504.76 $25.8 Million - $36.1 Million	71,482 Added 87.97%	152,735 $58.7 Million
Q4 2020 Feb 16, 2021	BUY	$292.7 - $370.96 $13.9 Million - $17.7 Million	47,593 Added 141.39%	81,253 $30.1 Million
Q3 2020 Nov 16, 2020	SELL	$268.51 - $400.74 $16.7 Million - $24.9 Million	-62,244 Reduced 64.9%	33,660 $10.4 Million
Q2 2020 Aug 14, 2020	SELL	$256.46 - $373.01 $77.7 Million - $113 Million	-303,089 Reduced 75.96%	95,904 $35.5 Million
Q1 2020 May 15, 2020	BUY	$209.2 - $335.53 $69.6 Million - $112 Million	332,804 Added 502.81%	398,993 $109 Million
Q4 2019 Feb 14, 2020	BUY	$288.29 - $335.49 $10.4 Million - $12.1 Million	36,018 Added 119.38%	66,189 $22 Million
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $15.7 Million - $22.2 Million	-58,768 Reduced 66.08%	30,171 $9.18 Million
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $14.3 Million - $17.5 Million	47,524 Added 114.75%	88,939 $32.7 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $15.7 Million - $18.5 Million	-57,594 Reduced 58.17%	41,415 $12.9 Million
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $12.3 Million - $16.6 Million	-45,260 Reduced 31.37%	99,009 $29.7 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $12.1 Million - $16 Million	43,459 Added 43.11%	144,269 $53 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $9.72 Million - $12.4 Million	42,604 Added 73.2%	100,810 $28.2 Million
Q1 2018 May 15, 2018	SELL	$209.54 - $253.91 $3.58 Million - $4.34 Million	-17,088 Reduced 22.7%	58,206 $13.8 Million
Q4 2017 Feb 14, 2018	SELL	$202.23 - $230.03 $1.19 Million - $1.35 Million	-5,880 Reduced 7.24%	75,294 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $14 Million - $17.4 Million	81,174	81,174 $16.2 Million

Others Institutions Holding ILMN

# of Institutions

852

Shares Held

138M

Call Options Held

1.41M

Put Options Held

1.66M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $20.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account